Predictive value of neutrophil-to-lymphocyte ratio and MELD score for short-term survival of patients with HBV-DeCi

Biomark Med. 2025 Jan;19(2):43-49. doi: 10.1080/17520363.2024.2448112. Epub 2025 Jan 9.

Abstract

Objective: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) combined with Model for End-Stage Liver Disease (MELD) score was evaluated for hepatitis B virus-associated decompensated cirrhosis (HBV-DeCi).

Methods: The 30-day mortality of 166 hBV-DeCi patients was examined. Receiver operating characteristic curve analysis and multivariate regression analysis were used to assess the performance of NLR for prediction of poor outcomes.

Results: The 30-day mortality rate was 10.2% (17/166). NLR was significantly lower in survivors than in non-survivors, and could be used for prognosis prediction in HBV-DeCi patients. Area under the curve was higher for NLR combined with MELD score than for each factor alone. (MELD score, AUC:0.864、NLR, AUC:0.781, Combined, AUC:0.920) The Odds ratio of MELD score is lower than NLR.(MELD score:1.447&NLR:1.745).

Conclusions: The findings demonstrate that NLR combined with MELD score has a high prognostic value for HBV-DeCi patients.

Keywords: Decompensated cirrhosis; MELD score; hepatitis B virus; mortality; neutrophil-to-lymphocyte ratio.

MeSH terms

  • Adult
  • Aged
  • End Stage Liver Disease / blood
  • End Stage Liver Disease / diagnosis
  • End Stage Liver Disease / mortality
  • Female
  • Hepatitis B / blood
  • Hepatitis B / complications
  • Hepatitis B / diagnosis
  • Hepatitis B / mortality
  • Hepatitis B virus / isolation & purification
  • Humans
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / virology
  • Lymphocyte Count
  • Lymphocytes* / cytology
  • Male
  • Middle Aged
  • Neutrophils* / cytology
  • Predictive Value of Tests
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Severity of Illness Index

Grants and funding

The work was supported by Key Research Project Education Department of Anhui Province (2022AH051267); Beijing Xisike Clinical Oncology Research Fundation (Y-HS202201-0168); WBE Liver Fibrosis Foundation (CFHPC2024027); Beijing Science and Technology Innovation Medical Development Foundation (KC2023-JX-0186-FQ034); Xinchang County Science and Technology plan project (JFZC2415). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.